Newbury Pharmaceuticals Reports Q4 EBITDA of SEK -5.1 Million
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
Newmark Posts Q3 Adjusted EPS of $0.48
Newmark reported Q3 adjusted EPS of $0.48, versus the FactSet estimate of $0.47.
L impact | EARNINGS | Oct 29, 2026, 01:03 PM UTC
Gulf Bank Reports 9-Month Operating Revenue of 143.1 Million Dinars
M impact | EARNINGS | Oct 29, 2026, 12:52 PM UTC
Newmark Expects 2026 Revenue of $3.70B-$3.80B
Newmark expects 2026 revenue of $3.70 billion to $3.80 billion, versus a FactSet estimate of $3.80 billion.
M impact | EARNINGS | Oct 29, 2026, 12:52 PM UTC
Newmark Group sets FY adjusted EPS outlook at USD 1.8-1.9
M impact | EARNINGS | Oct 29, 2026, 12:52 PM UTC
Newmark Guides 2026 Adjusted EPS to $1.80-$1.90
Newmark expects 2026 adjusted EPS of $1.80-$1.90, versus a FactSet estimate of $1.91.
M impact | EARNINGS | Oct 29, 2026, 12:52 PM UTC
NewMarket Reports Nine-Month Net Sales of $716.5M, Net Income of $124.11M
For the nine months of 2026, net sales rose 3.8% year over year, net income increased 23.8% to $124.11 million, and diluted EPS increased 26.5% to $13.5.
M impact | EARNINGS | Oct 29, 2026, 12:51 PM UTC